Top holdings
Name
Weight
6.11 %
4.99 %
4.74 %
4.74 %
4.48 %
4.45 %
4.42 %
4.16 %
4.15 %
4.13 %
3.90 %
3.83 %
3.78 %
3.71 %
3.66 %
3.14 %
3.05 %
2.89 %
2.70 %
2.41 %
2.36 %
2.35 %
2.22 %
2.07 %
1.75 %
1.63 %
1.30 %
0.87 %
0.83 %
0.83 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Analysis
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Top holdings
Name
Weight
6.11 %
4.99 %
4.74 %
4.74 %
4.48 %
4.45 %
4.42 %
4.16 %
4.15 %
4.13 %
3.90 %
3.83 %
3.78 %
3.71 %
3.66 %
3.14 %
3.05 %
2.89 %
2.70 %
2.41 %
2.36 %
2.35 %
2.22 %
2.07 %
1.75 %
1.63 %
1.30 %
0.87 %
0.83 %
0.83 %
Analyst ratings
FAQ
- What is GNOM?
- Does GNOM pay dividends?
- What stocks are in GNOM?
- What is the current assets under management for GNOM?
- What is GNOM average volume?
- What is GNOM expense ratio?
- What is GNOM inception date?
What is GNOM?
The GNOM ETF, or Goldman Sachs Future Tech Leaders Equity ETF, focuses on investing in innovative technology companies. It aims to provide exposure to firms driving advancements in areas like artificial intelligence, cloud computing, and cybersecurity, offering investors a way to tap into future growth potential in the tech sector.
Does GNOM pay dividends?
Yes, the Global X Genomics & Biotechnology ETF does pays dividends, with
the most recent payment being
$0.01
per share. The last ex-dividend date was on December 30, 2021, and the next ex-dividend date has not been announced yet
What stocks are in GNOM?
As of today, Global X Genomics & Biotechnology ETF inlcudes 42 holdings, with 39 of them being companies from 5 different countries and 2 sectors. The most weighted holdings are Natera (6.11%), Veracyte (4.99%) and BioMarin Pharmaceutical (4.74%)
What is the current assets under management for GNOM?
Assets under management of Global X Genomics & Biotechnology ETF is $78 M
What is GNOM average volume?
Average volume of Global X Genomics & Biotechnology ETF is $42 K
What is GNOM expense ratio?
Expense ratio of Global X Genomics & Biotechnology ETF is 0.50%
What is GNOM inception date?
Inception date of Global X Genomics & Biotechnology ETF is April 5, 2019